Synaptics Reports Second Quarter Fiscal 2026 Results Core IoT product sales increased 53% year-over-year Q2'26 Financial Results Revenue of $302.5 million, up 13% year-over-yearFiscal second quarter Core IoT product sales grew by 53% year-over-yearGAAP gross margin of 43.5%Non-GAAP gross margin of 53.6%GAAP loss per share of $0.38Non-GAAP diluted earnings per share of $1.21 SAN JOSE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: ) today reported financial results for its second quarter of fiscal 2026 ended December 27, 2025. Net revenue for the second qua...
American Assets Trust, Inc. Reports Fourth Quarter and Year End 2025 Financial Results SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “company”) today reported financial results for its fourth quarter and year ended December 31, 2025. Fourth Quarter Highlights Net income available to common stockholders of $3.1 million and $55.6 million for the three months and year ended December 31, 2025, respectively, or $0.05 and $0.92 per diluted share, respectively.FFO of $0.47 and $2.00 per diluted share for the three months and year ended December 3...
Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” Middlefield Banc Corp. Proposed Merger with Farmers National Banc Corp. Recommendation Highlights Strategic Benefits and Value Creation of Merger The Board of Directors Urges Shareholders to Vote by February 9, 2026, at 11:59 p.m., ET MIDDLEFIELD, Ohio, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that Institutional Shareholder Services, Inc. (“ISS”), an independent proxy advisory firm, has recommended shareholders vote “FOR” all proposals at the Special Meeting of Sharehol...
Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2025 Results MARIETTA, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for fourth quarter and full year ended December 31, 2025, on Thursday, February 19, 2026, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at , concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, F...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 14,250 shares of its common stock to five newly-hired employees, with a grant date of January 20, 2026 (the "Grant Date"). The restricted stock units were granted pu...
American Assets Trust, Inc. Releases Tax Status of 2025 Distributions SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “Company”) announced today the tax treatment of its 2025 dividend distributions as follows: Security Descriptions: Common StockCUSIP: 024013104Ticker Symbol: AAT Record DatePayable DateTotal Distribution Per ShareAllocable to 2025Taxable Ordinary DividendLT Capital GainUnrecaptured Sec. 1250 GainSection 199A DividendsReturn of Capital03/06/2503/20/25$0.340$0.340$0.140480$0.059651$0.042897$0.140480$0.13986906/05/2506/19/25$0.340$0....
Synaptics to Report Second Quarter Fiscal 2026 Results on February 5, 2026 SAN JOSE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will report financial results for the second quarter of fiscal 2026 on Thursday, February 5, 2026, after the market closes. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), to discuss the results. To participate on the live call, analysts and investors should pre-register at . Registrants will receive dial-in information and a unique passcod...
American Assets Trust, Inc. Announces Fourth Quarter and Year-End 2025 Earnings Release Date and Conference Call Information SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its fourth quarter and year-end 2025 earnings in a press release to be issued after the market closes on Tuesday, February 3, 2026. Senior management will hold a conference call for its fourth quarter and year-end 2025 earnings on Wednesday, February 4, 2026 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 a...
Synaptics to Participate at Upcoming Investor Conference Tuesday, January 13, 2026 SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in upcoming investor conference. Ken Rizvi, Chief Financial Officer, will present at the 28th Annual Needham Growth Conference on Tuesday, January 13, 2026 at 10:30 AM PT. To view the webcast or access a replay, please visit . About Synaptics Incorporated: Synaptics (Nasdaq: ) is driving innovation in AI at the Edge, bringing AI closer to end users and transforming how we engage with in...
Synaptics Appoints Venkatesh (Venk) Nathamuni to Board of Directors SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) (“Company”) today announced that on December 29, 2025, its Board of Directors (“Board”) appointed Venkatesh (Venk) Nathamuni to serve as a member of the Company’s Board and as a member of its Audit Committee, with service commencing on January 1, 2026. Mr. Nathamuni has more than 30 years of leadership experience with deep expertise in corporate finance, strategy, mergers and acquisitions, investor relations, and public company governan...
Donegal Group Inc. Announces Quarterly Dividend MARIETTA, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on February 17, 2026 to stockholders of record as of the close of business on February 3, 2026. About Donegal Group Inc. Donegal Group Inc. is an insurance holding company whose insurance subsidiaries and affilia...
Synaptics Showcases Edge AI Innovations at CES 2026 Featuring Synaptics Astra™, Veros™, and Multimodal Sensing SAN JOSE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will showcase a broad portfolio of AI-native processing, sensing, and connectivity technologies at CES 2026. These solutions demonstrate how intelligence at the Edge transforms real-world applications across consumer, industrial, smart home, and enterprise markets.As global demand grows for devices that can interpret their environment, make context-aware decisions, and...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 3,600 shares of its common stock to three newly-hired employees, with a grant date of December 9, 2025 (the "Grant Date"). The restricted stock units were granted pu...
A director at Synaptics Inc sold 18,285 shares at 80.291USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025 SAN JOSE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in upcoming investor conferences. Rahul Patel, President and Chief Executive Officer, will participate in UBS’ Global Technology and AI Conference 2025 on Tuesday, December 2, 2025Rahul Patel, President and Chief Executive Officer, and Ken Rizvi, CFO, will present at Barclays 23rd Annual Global Technology Conference on Wednesday, December 10, 2025 at ...
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 37th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 37th Annual Healthcare Conference at 2:30 pm ET on December 3rd, 2025. Interested parties can access the live and archived webcast at . About TELA Bio, In...
Middlefield Banc Corp. Announces 2025 Fourth-Quarter Cash Dividend Payment MIDDLEFIELD, Ohio, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.21 per common share. The 2025 fourth-quarter dividend is payable on December 12, 2025, to shareholders of record on November 28, 2025. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the Bank holding Company of The Middlefield Banking Company, with total assets of $1.98 billion at September 30, 202...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a gra...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.